IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (15)
Jefferies
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 | Bill.com Holdin | Technology | 22 | 9 | GS | BAML | JEFF | 97% | 61.4% | ||
Nov 8 | TELA Bio Inc. | Health-Care | 13 | 4 | JEFF | PPRJ | 31.8% | 2.7% | |||
Oct 25 | Phathom Pharmac | Health-Care | 19 | 9 | GS | JEFF | EVCR | 9% | 29.5% | ||
Sep 26 | Oportun Financi | Finance | 15 | 6 | BRCL | JPM | JEFF | 27.2% | 7.8% | ||
Sep 18 | IGM Biosciences | Health-Care | 16 | 10 | JEFF | PPRJ | Stifel | 16% | 51.9% | ||
Jul 18 | Genmab A/S | Health-Care | 17.8 | 28 | BAML | MS | JEFF | 20.7% | 1.4% | ||
Jun 27 | Morphic Holding | NA | 15 | 6 | JEFF | COWN | BMO | 17.5% | 20% | ||
Jun 27 | BridgeBio Pharm | NA | 17 | 20 | JPM | GS | JEFF | 24.3% | 62.1% | ||
Jun 20 | Akero Therapeut | NA | 16 | 5 | JPM | JEFF | EVCR | 51.9% | 14.5% | ||
May 23 | IDEAYA Bioscien | NA | 10 | 5 | JPM | CITI | JEFF | 34.4% | 11.9% | ||
May 23 | Bicycle Therape | NA | 14 | 4 | GS | JEFF | PPRJ | 22.8% | -14.3% | ||
May 9 | Milestone Pharm | NA | 15 | 5 | JEFF | COWN | PPRJ | 17.9% | 2.5% | ||
May 9 | Mayville Engine | NA | 17 | 6 | BARD | CITI | JEFF | 45% | -3.1% | ||
Mar 29 | Lyft Inc. | NA | 72 | 32 | JPM | CS | JEFF | 219.6% | 8.7% | ||
Feb 15 | Stealth BioTher | NA | 12 | 6 | JEFF | EVCR | BMO | 17.5% | -0.8% |
*
Lead manager or one of top three managers in an underwriting team.